NCT03262246View on ClinicalTrials.gov

Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

June 2, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2018

Conditions
Amyloid Angiopathy
Interventions
OTHER

medical report consultation

investigators consult medical report concerning patient identified for cerebral amyloid angiopathy

Trial Locations (1)

75014

Groupe Hospitalier Paris Saint Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT03262246 - Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid | Biotech Hunter | Biotech Hunter